Literature DB >> 21206180

Efficacy of gabapentin for radiculopathy caused by lumbar spinal stenosis and lumbar disk hernia.

Omur Kasimcan1, Hulagu Kaptan.   

Abstract

The efficacy of gabapentin monotherapy was investigated against both acute or chronic radicular pain caused by lumbar disk hernia (LDH) or lumbar spinal stenosis (LSS). Seventy-eight patients with radicular pain, 10 males and 68 females aged 23 to 76 years (mean 49.4 years), caused by LSS in 45 patients or LDH in 33 patients were treated with oral administration of gabapentin and were followed up for 3 months. The evaluation included neurological examination, Odom's criteria, visual analog pain scale (VAS), and walking distance. Gabapentin treatment resulted in decreased VAS scores in both groups. Odom's criteria scores had improved to excellent or good in 36 patients with LSS and 28 patients with LDH. Furthermore, walking distance was significantly longer at the 3rd month of the treatment protocol. Eight patients discontinued gabapentin therapy because of the side effects. Gabapentin could be an option in the conservative management of acute or chronic radicular pain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21206180     DOI: 10.2176/nmc.50.1070

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  12 in total

Review 1.  Current concepts for lumbar disc herniation.

Authors:  Thami Benzakour; Vasilios Igoumenou; Andreas F Mavrogenis; Ahmed Benzakour
Journal:  Int Orthop       Date:  2018-11-30       Impact factor: 3.075

Review 2.  Gabapentin for chronic neuropathic pain in adults.

Authors:  Philip J Wiffen; Sheena Derry; Rae F Bell; Andrew Sc Rice; Thomas Rudolf Tölle; Tudor Phillips; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-06-09

Review 3.  Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

Authors:  R Andrew Moore; Philip J Wiffen; Sheena Derry; Thomas Toelle; Andrew S C Rice
Journal:  Cochrane Database Syst Rev       Date:  2014-04-27

4.  The Influence of Exercise on Perceived Pain and Disability in Patients With Lumbar Spinal Stenosis: A Systematic Review of Randomized Controlled Trials.

Authors:  Jarrett Slater; Morey J Kolber; Kristen C Schellhase; Chetan K Patel; Carey E Rothschild; Xinliang Liu; William J Hanney
Journal:  Am J Lifestyle Med       Date:  2015-02-16

5.  Role of vitamin D3 in treatment of lumbar disc herniation--pain and sensory aspects: study protocol for a randomized controlled trial.

Authors:  Mahsa Sedighi; Ali Haghnegahdar
Journal:  Trials       Date:  2014-09-25       Impact factor: 2.279

6.  Effects of Nasal Calcitonin vs. Oral Gabapentin on Pain and Symptoms of Lumbar Spinal Stenosis: A Clinical Trial Study.

Authors:  Kaveh Haddadi; Leila Asadian; Ahdie Isazade
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2016-07-05

Review 7.  Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies.

Authors:  Amy Wachholtz; Gerardo Gonzalez; Edward Boyer; Zafar N Naqvi; Christopher Rosenbaum; Douglas Ziedonis
Journal:  Subst Abuse Rehabil       Date:  2011-08-18

8.  Validation of the Korean Version of the DN4 Diagnostic Questionnaire for Neuropathic Pain in Patients with Lumbar or Lumbar-Radicular Pain.

Authors:  Ho Joong Kim; Joon Hee Park; Didier Bouhassira; Jae Hoon Shin; Bong Soon Chang; Choon Ki Lee; Chang Hyun Baek; Jin S Yeom
Journal:  Yonsei Med J       Date:  2016-03       Impact factor: 2.759

9.  Membrane-Stabilizing Agents Improve Quality-of-Life Outcomes for Patients with Lumbar Stenosis.

Authors:  Sachin Bansal; Daniel Lubelski; Nicolas R Thompson; Ali A Shah; Daniel J Mazanec; Edward C Benzel; Tagreed Khalaf
Journal:  Global Spine J       Date:  2015-07-14

10.  Novel Treatment of Radicular Pain With a Multi-Mechanistic Combination Topical Agent: A Case Series and Literature Review.

Authors:  Pegah Safaeian; Ryan Mattie; Matthew Hahn; Christopher T Plastaras; Zachary L McCormick
Journal:  Anesth Pain Med       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.